Gluthatione-S-transferase T1-null genotype predisposes adults to acute promyelocytic leukemia; A case-control study

Asian Pacific Journal of Cancer Prevention

Volumn 12, Issue 5, 2011, Pages 1279-1282

  Mandegary, Ali ^a   Rostami, Shahrbanou ^b   Alimoghaddam, Kamran ^b,c   Ghavamzadeh, Ardeshir ^b   Ghahremani, Mohammad Hossein ^c  

^a KERMAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Acute promyelocytic leukemia; GSTM1; GSTP1; GSTT1; Iran; Polymorphism

Indexed keywords

EID: 84857939960     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Ali-Osman F, Akande O, Antoun G, et al (1997). Molecular cloning, characterization, and expression in Escherichia coli of full-length cDNAs of three human glutathione S-transferase Pi gene variants. Evidence for differential catalytic activity of the encoded proteins. J Biol Chem, 272, 10004-12.
2. Alidoust L, Zafarghandi M, Agah M, et al (2007). Glutathione-S-transferase M1, T1 and P1 gene polymorphisms in type I autoimmune hepatitis: a case-control study. Indian J Gastroenterol, 26, 97-9.
3. Allan JM, Wild CP, Rollinson S, et al (2001). Polymorphism in glutathione s-transferase P1 is associated with susceptibility to chemotherapy-induced leukaemia. PNAS, 98, 11592-7.
4. Alves S, Amorim A, Ferreira F, et al (2002). The GSTM1 and GSTT1 genetic polymorphisms and susceptibility to acute lymphoblastic leukemia in children from north Portugal. Leukemia, 16, 1565-7.
5. Arruda VR, Lima CS, Grignoli CR, et al (2001). Increased risk for acute myeloid leukaemia in individuals with glutathione S-transferase mu 1 (GSTM1) and theta 1 (GSTT1) gene defects. Eur J Haematol, 66, 383-8.
6. Crump C, Chen C, Appelbaum FR, et al (2000). Glutathione stransferase thea 1 gene deletion and risk of acute myeloid leukaemia. Cancer Epidemiol Biomarkers Prev, 9, 457-60.
7. Davies SM, Robison LL, Buckley JD, et al (2000). Glutathione s-transferase polymorphisms in childhood with myeloid leukaemia: a childhood's cancer group study. Cancer Epidemiol Biomarkers Prev, 9, 563-6.
8. Ghavamzadeh A, Alimoghaddam K, Ghaffari SH, et al (2006). Treatment of acute promyelocytic leukemia with arsenic trioxide without ATRA and/or chemotherapy. Ann Oncol, 17, 131-4.
9. Grignani F, Fagioli M, Alcalay M, et al (1994). Acute promyelocytic leukemia: from genetics to treatment. Blood, 83, 10-25.
10. Haase D, Binder C, Bunger J, et al (2002). Increased risk for therapy-associated hematologic malignancies in patients with carcinoma of the breast and combined homozygous gene deletions of glutathione transferases M1 and T1. Leuk Res, 26, 249-54.
11. Hayes JD, Strange RC (2000). Glutathione s-transferase polymorphisms and their biological consequences. Pharmacology, 61, 154-66.
12. Lemos MC, Cabrita FJ, Silva HA, et al (1999). Genetic polymorphism of CYP2D6, GSTM1 and NAT2 and susceptibility to haematological neoplasias. Carcinogenesis, 20, 1225-9.
13. Mandegary A, Hosseini R, Ghaffari SH, et al (2010). The expression of p38, ERK1 and Bax proteins has increased during the treatment of newly diagnosed acute promyelocytic leukemia with arsenic trioxide. Ann Oncol, 21, 1884-90.
14. Mannervik B, Alin P, Guthenberg C, et al (1985). Identification of three classes of cytosolic glutathione transferase common to several mammalian species: correlation between structural data and enzymatic properties. Proc Natl Acad Sci U S A, 82, 7202-6.
15. Miller SA, Dykes DD, Polesky HF (1988). A simple salting out procedure for extracting DNA from human nucleated cells. Nucl Acids Res, 16, 1215.
16. Mohammadzadeh Ghobadloo S, Yaghmaei B, Allameh A, et al (2006). Polymorphisms of glutathione S-transferase M1, T1, and P1 in patients with HBV-related liver cirrhosis, chronic hepatitis, and normal carriers. Clin Biochem, 39, 46-9.
17. Moradi M, Mojtahedzadeh M, Mandegari A, et al (2009). The role of glutathione-S-transferase polymorphisms on clinical outcome of ALI/ARDS patient treated with N-acetylcysteine. Respir Med, 103, 434-41.
18. Naoe T, Takeyama K, Yokozawa T, et al (2000). Analysis of genetic polymorphism in NQO1, GST-M1, GST-T1, and CYP3A4 in 469 Japanese patients with therapy-related leukemia/ myelodysplastic syndrome and de novo acute myeloid leukemia. Clin Cancer Res, 6, 4091-5.
19. Rebbeck TR (1997). Molecular epidemiology of the human glutathione S-transferase genotypes GSTM1 and GSTT1 in cancer susceptibility. Cancer Epidemiol Biomarkers Prev, 6, 733-43.
20. Rollinson S, Roddam P, Kane E, et al (2000). Polymorphic variation within the glutathione S-transferase genes and risk of adult acuteleukaemia. Carcinogenesis, 21, 43-7.
21. Saadat I, Saadat M (2000). The glutathione S-transferase mu polymorphism and susceptibility to acute lymphocytic leukemia. Cancer Lett, 158, 43-5.
22. Saadat I, Saadat M (2001). Glutathione S-transferase M1 and T1 null genotypes and the risk of gastric and colorectal cancers. Cancer Lett, 169, 21-6.
23. Sasai Y, Horiike S, Misawa S, et al (1999). Genotype of glutathione S-transferase and other genetic configurations in myelodysplasia. Leuk Res, 23, 975-81.
24. Souza CL, Barbosa CG, de Moura Neto JP, et al (2008). Polymorphisms in the glutathione S-transferase theta and mu genes and susceptibility to myeloid leukemia in Brazilian patients. Gene Mol Biol, 31, 39-41.
25. Torkaman-Boutorabi A, Hoormand M, Naghdi N, et al (2007). Genotype and allele frequencies of N-acetyltransferase 2 and glutathione S-transferase in the Iranian population. Clin Exp Pharmacol Physiol, 34, 1207-11.
26. Ye Z, Song H (2005). Glutathione s-transferase polymorphisms (GSTM1, GSTP1 and GSTT1) and the risk of acute leukaemia: a systematic review and meta-analysis. Eur J Cancer, 41, 980-9.